TrialInfectious diseases of poverty2025

Collateral benefits of ivermectin mass drug administration designed for malaria against headlice in Mopeia, Mozambique: a cluster randomised controlled trial.

Joanna Furnival-Adams et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.